Perchlorate January 2014
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Sodium Perchlorate, Anhydrous
Sodium perchlorate, anhydrous sc-203398 Material Safety Data Sheet Hazard Alert Code Key: EXTREME HIGH MODERATE LOW Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME Sodium perchlorate, anhydrous STATEMENT OF HAZARDOUS NATURE CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO OSHA 29 CFR 1910.1200. NFPA FLAMMABILITY0 HEALTH2 HAZARD INSTABILITY2 OX SUPPLIER Santa Cruz Biotechnology, Inc. 2145 Delaware Avenue Santa Cruz, California 95060 800.457.3801 or 831.457.3800 EMERGENCY: ChemWatch Within the US & Canada: 877-715-9305 Outside the US & Canada: +800 2436 2255 (1-800-CHEMCALL) or call +613 9573 3112 SYNONYMS Cl-Na-O4, Na-Cl-O4, "perchloric acid, sodium salt", Irenat., anti-thyroid Section 2 - HAZARDS IDENTIFICATION CHEMWATCH HAZARD RATINGS Min Max Flammability: 0 Toxicity: 2 Body Contact: 2 Min/Nil=0 Low=1 Reactivity: 2 Moderate=2 High=3 Chronic: 2 Extreme=4 CANADIAN WHMIS SYMBOLS 1 of 8 EMERGENCY OVERVIEW RISK Explosive when mixed with combustible material. Harmful if swallowed. Irritating to eyes. POTENTIAL HEALTH EFFECTS ACUTE HEALTH EFFECTS SWALLOWED ! Accidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram may be fatal or may produce serious damage to the health of the individual. ! Symptoms of exposure to perchlorates include shortness of breath, difficulty breathing and a bluish discoloration of the skin. The effects may be delayed for several hours following exposure. <\p>. ! Nausea and vomiting are almost always apparent after chlorate poisonings usually with upper stomach pain. Diarrhea may also occur. <\p>. EYE ! This material can cause eye irritation and damage in some persons. SKIN ! There is some evidence to suggest that this material can cause inflammation of the skin on contact in some persons. -
Physician Perchlorate Fact Sheet
Physician Fact Sheet PERCHLORATE Environmental Epidemiology and Toxicology Division HIGHLIGHTS: Perchlorate competitively inhibits the uptake of iodide by the thyroid gland potentially affecting thyroid function. Pregnant women and their developing fetus may be more susceptible to the effects of perchlorate because of the stress that pregnancy places on the thyroid gland. Disruption of thyroid function could put pregnant women at greater risk for pregnancy-related complications such as preeclampsia, placental abruption, and low birth weight infants. An adequate iodine intake may negate the potential effects. Exposure levels that affect thyroid function have not been well demonstrated in humans. Currently, a National Primary Drinking Water Regulation for perchlorate does not exist. For more information, call the Texas Department of Health Environmental Epidemiology and Toxicology Division at (800)588-1248. What is Perchlorate? How does perchlorate get into the body? -1 Perchlorate (ClO4 ) is the most oxygenated member of Drinking water contaminated with perchlorate is the a series of compounds made up of chlorine and most likely way that perchlorate can get into the body. oxygen. It can form an acid or a salt in combination Perchlorate is not well absorbed through the skin. with a hydrogen ion (H+) or another cation such as sodium, potassium, or ammonium ion. Perchlorate What health effects are associated with salts, which have been widely used as an oxidizer in perchlorate? solid propellants for rockets and missiles since the mid- 1940s, have a finite shelf-life and must periodically be Perchlorate competitively inhibits the uptake of iodide replaced. As a result, large volumes of perchlorate by the thyroid gland through its effect on a transport have been disposed of since the 1950s. -
Sodium Chloride (Halite, Common Salt Or Table Salt, Rock Salt)
71376, 71386 Sodium chloride (Halite, Common Salt or Table Salt, Rock Salt) CAS number: 7647-14-5 Product Description: Molecular formula: NaCl Appearance: white powder (crystalline) Molecular weight: 58.44 g/mol Density of large crystals: 2.17 g/ml1 Melting Point: 804°C1 Density: 1.186 g/ml (5 M in water)2 2 Solubility: 1 M in H2O, 20°C, complete, clear, colorless 2 pH: 5.0-8.0 (1 M in H2O, 25°C) Store at room temperature Sodium chloride is geologically stable. If kept dry, it will remain a free-flowing solid for years. Traces of magnesium or calcium chloride in commercial sodium chloride adsorb moisture, making it cake. The trace moisture does not harm the material chemically in any way. 71378 BioUltra 71386 BioUltra for molecular biology, 5 M Solution The products are suitable for different applications like purification, precipitation, crystallisation and other applications which require tight control of elemental content. Trace elemental analyses have been performed for all qualities. The molecular biology quality is also tested for absence of nucleases. The Certificate of Analysis provides lot-specific results. Much of the sodium chloride is mined from salts deposited from evaporation of brine of ancient oceans, or recovered from sea water by solar evaporation. Due to the presence of trace hygroscopic minerals, food-grade salt has a small amount of silicate added to prevent caking; as a result, concentrated solutions of "table salt" are usually slightly cloudy in appearance. 71376 and 71386 do not contain any anti-caking agent. Applications: Sodium chloride is a commonly used chemical found in nature and in all body tissue, and is considered an essential nutrient. -
Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility Through Gene-Environment Interactions
toxics Review Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility through Gene-Environment Interactions Dylan J. Wallis 1 , Lisa Truong 2 , Jane La Du 2, Robyn L. Tanguay 2 and David M. Reif 1,* 1 Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA; [email protected] 2 Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA; [email protected] (L.T.); [email protected] (J.L.D.); [email protected] (R.L.T.) * Correspondence: [email protected] Abstract: Exposure to endocrine-disrupting chemicals (EDCs) is linked to myriad disorders, charac- terized by the disruption of the complex endocrine signaling pathways that govern development, physiology, and even behavior across the entire body. The mechanisms of endocrine disruption in- volve a complex system of pathways that communicate across the body to stimulate specific receptors that bind DNA and regulate the expression of a suite of genes. These mechanisms, including gene regulation, DNA binding, and protein binding, can be tied to differences in individual susceptibility across a genetically diverse population. In this review, we posit that EDCs causing such differential responses may be identified by looking for a signal of population variability after exposure. We begin Citation: Wallis, D.J.; Truong, L.; La by summarizing how the biology of EDCs has implications for genetically diverse populations. We Du, J.; Tanguay, R.L.; Reif, D.M. then describe how gene-environment interactions (GxE) across the complex pathways of endocrine Uncovering Evidence for Endocrine- signaling could lead to differences in susceptibility. We survey examples in the literature of individual Disrupting Chemicals That Elicit susceptibility differences to EDCs, pointing to a need for research in this area, especially regarding Differential Susceptibility through the exceedingly complex thyroid pathway. -
Calcium Chloride CAS N°:10043-52-4
OECD SIDS CALCIUM CHLORIDE FOREWORD INTRODUCTION Calcium chloride CAS N°:10043-52-4 UNEP PUBLICATIONS 1 OECD SIDS CALCIUM CHLORIDE SIDS Initial Assessment Report For SIAM 15 Boston, USA 22-25th October 2002 1. Chemical Name: Calcium chloride 2. CAS Number: 10043-52-4 3. Sponsor Country: Japan National SIDS Contact Point in Sponsor Country: Mr. Yasuhisa Kawamura Director Second Organization Div. Ministry of Foreign Affairs 2-2-1 Kasumigaseki, Chiyoda-ku Tokyo 100 4. Shared Partnership with: 5. Roles/Responsibilities of the Partners: • Name of industry sponsor Tokuyama Corporation /consortium Mr. Shigeru Moriyama, E-mail: [email protected] Mr. Norikazu Hattori, E-mail: [email protected] • Process used 6. Sponsorship History • How was the chemical or This substance is sponsored by Japan under ICCA Initiative and category brought into the is submitted for first discussion at SIAM 15. OECD HPV Chemicals Programme ? 7. Review Process Prior to The industry consortium collected new data and prepared the the SIAM: updated IUCLID, and draft versions of the SIAR and SIAP. Japanese government peer-reviewed the documents, audited selected studies. 8. Quality check process: 9. Date of Submission: 10. Date of last Update: 2 UNEP PUBLICATIONS OECD SIDS CALCIUM CHLORIDE 11. Comments: No testing (X) Testing ( ) The CaCl2-HPV Consortium members: (Japan) Asahi Glass Co., Ltd. Central Glass Co., Ltd. Sanuki Kasei Co., Ltd. Tokuyama Corporation [a global leader of the CaCl2-HPV Consortium] Tosoh Corporation (Europe) Brunner Mond (UK) Ltd. Solvay S.A. (North America) The Dow Chemical Company General Chemical Industrial Products Inc. Tetra Technologies, Inc. -
Writing Total and Net Ionic Equations
WRITING TOTAL AND NET IONIC EQUATIONS http://www.csun.edu/~hcchm001/FreshChemHandouts.html 1. Write the overall equation including the correct designations for the physical state of the substances (s, l, g, aq). Balance this equation. Most of these kinds of equations are double displacement reactions: AX + BY 6 AY + BX 2. For the total ionic equations, write strong electrolytes in solution in the form of aqueous ions. (a) Strong acids. The common strong acids and their aqueous ions are: HI Hydroiodic acid H+-(aq) + I (aq) HBr Hydrobromic acid H+-(aq) + Br (aq) HCl Hydrochloric acid H+-(aq) + Cl (aq) +- HNO33Nitric acid H (aq) + NO (aq) +- HClO44Perchloric acid H (aq) + ClO (aq) +-2 H24SO Sulfuric acid 2 H (aq) + SO4(aq) (b) Strong bases. Strong bases are the hydroxides of the alkali (Group IA) and alkaline earth (Group IIA) metals ions which are sufficiently soluble. The common strong bases and their aqueous ions are: LiOH Lithium hydroxide Li+-(aq) + OH (aq) NaOH Sodium hydroxide Na+-(aq) + OH (aq) KOH Potassium hydroxide K+-(aq) + OH (aq) +2 - Sr(OH)2Strontium hydroxide Sr (aq) + 2 OH (aq) +2 - Ba(OH)2 Barium hydroxide Ba (aq) + 2 OH (aq) (c) Soluble salts. Determinations of the solubility of a salt may be made by reference to SOLUBILITIES OF IONIC COMPOUNDS. Soluble salts are written as their aqueous ions: NaCl(aq) Sodium chloride Na+-(aq) + Cl (aq) +-2 K24SO (aq) Potassium sulfate 2 K (aq) + SO4(aq) +-2 Li23CO (aq) Lithium carbonate 2 Li (aq) + CO3(aq) +-3 Na34PO (aq) Sodium phosphate 3 Na (aq) + PO4(aq) +-2 (NH42) SO4(aq) Ammonium sulfate 2 NH4(aq) + SO4 (aq) 3. -
Liothyronine Sodium(BANM, Rinnm) Potassium Perchlorate
2174 Thyroid and Antithyroid Drugs with methodological limitations. However, a controlled trial of In myxoedema coma liothyronine sodium may be liothyronine with paroxetine could not confirm any advantage of given intravenously in a dose of 5 to 20 micrograms by 3 O additive therapy. slow intravenous injection, repeated as necessary, usu- 1. Aronson R, et al. Triiodothyronine augmentation in the treat- HO I ally at intervals of 12 hours; the minimum interval be- ment of refractory depression: a meta-analysis. Arch Gen Psychi- OH atry 1996; 53: 842–8. tween doses is 4 hours. An alternative regimen advo- 2. Altshuler LL, et al. Does thyroid supplementation accelerate tri- NH2 cates an initial dose of 50 micrograms intravenously cyclic antidepressant response? A review and meta-analysis of I O the literature. Am J Psychiatry 2001; 158: 1617–22. followed by further injections of 25 micrograms every 3. Appelhof BC, et al. Triiodothyronine addition to paroxetine in I 8 hours until improvement occurs; the dosage may the treatment of major depressive disorder. J Clin Endocrinol then be reduced to 25 micrograms intravenously twice Metab 2004; 89: 6271–6. (liothyronine) daily. Obesity. Thyroid drugs have been tried in the treatment of obes- Liothyronine has also been given in the diagnosis of ity (p.2149) in euthyroid patients, but they produce only tempo- NOTE. The abbreviation T3 is often used for endogenous tri-io- hyperthyroidism in adults. Failure to suppress the up- rary weight loss, mainly of lean body-mass, and can produce se- dothyronine in medical and biochemical reports. Liotrix is USAN rious adverse effects, especially cardiac complications.1 for a mixture of liothyronine sodium with levothyroxine sodium. -
Fate of Sodium Pertechnetate-Technetium-99M
JOURNAL OF NUCLEAR MEDICINE 8:50-59, 1967 Fate of Sodium Pertechnetate-Technetium-99m Dr. Muhammad Abdel Razzak, M.D.,1 Dr. Mahmoud Naguib, Ph.D.,2 and Dr. Mohamed El-Garhy, Ph.D.3 Cairo, Egypt Technetium-99m is a low-energy, short half-life iostope that has been recently introduced into clinical use. It is available as the daughter of °9Mowhich is re covered as a fission product or produced by neutron bombardement of molyb denum-98. The aim of the present work is to study the fate of sodium pertechnetate 9OmTc and to find out any difference in its distribution that might be caused by variation in the method of preparation of the parent nuclide, molybdenum-99. MATERIALS & METHODS The distribution of radioactive sodium pertechnetate milked from 99Mo that was obtained as a fission product (supplied by Isocommerz, D.D.R.) was studied in 36 white mice, weighing between 150 and 250 gm each. Normal isotonic saline was used for elution of the pertechnetate from the radionuclide generator. The experimental animals were divided into four equal groups depending on the route of administration of the radioactive material, whether intraperitoneal, in tramuscular, subcutaneous or oral. Every group was further subdivided into three equal subgroups, in order to study the effect of time on the distribution of the pertechnetate. Thus, the duration between administration of the radio-pharma ceutical and sacrificing the animals was fixed at 30, 60 and 120 minutes for the three subgroups respectively. Then the animals were dissected and the different organs taken out.Radioactivityin an accuratelyweighed specimen from each organ was estimated in a scintillation well detector equipped with one-inch sodium iodide thallium activated crystal. -
Package Insert TECHNETIUM Tc99m GENERATOR for the Production of Sodium Pertechnetate Tc99m Injection Diagnostic Radiopharmaceuti
NDA 17693/S-025 Page 3 Package Insert TECHNETIUM Tc99m GENERATOR For the Production of Sodium Pertechnetate Tc99m Injection Diagnostic Radiopharmaceutical For intravenous use only Rx ONLY DESCRIPTION The technetium Tc99m generator is prepared with fission-produced molybdenum Mo99 adsorbed on alumina in a lead-shielded column and provides a means for obtaining sterile pyrogen-free solutions of sodium pertechnetate Tc99m injection in sodium chloride. The eluate should be crystal clear. With a pH of 4.5-7.5, hydrochloric acid and/or sodium hydroxide may have been used for Mo99 solution pH adjustment. Over the life of the generator, each elution will provide a yield of > 80% of the theoretical amount of technetium Tc99m available from the molybdenum Mo99 on the generator column. Each eluate of the generator should not contain more than 0.0056 MBq (0.15 µCi) of molybdenum Mo99 per 37 MBq, (1 mCi) of technetium Tc99m per administered dose at the time of administration, and not more than 10 µg of aluminum per mL of the generator eluate, both of which must be determined by the user before administration. Since the eluate does not contain an antimicrobial agent, it should not be used after twelve hours from the time of generator elution. PHYSICAL CHARACTERISTICS Technetium Tc99m decays by an isomeric transition with a physical half-life of 6.02 hours. The principal photon that is useful for detection and imaging studies is listed in Table 1. Table 1. Principal Radiation Emission Data1 Radiation Mean %/Disintegration Mean Energy (keV) Gamma-2 89.07 140.5 1Kocher, David C., “Radioactive Decay Data Tables,” DOE/TIC-11026, p. -
Sodium Chlorate Process Liquor De-Chromed SN
SAFETY DATA SHEET This SDS adheres to the standards and regulatory requirements of the United States and may not meet the regulatory requirements in other countries. 1. Identification Product identifier Sodium Chlorate Process Liquor De-chromed SN Other means of identification De-chromed blend of Crystallizer Feed Liquor and Mother Liquor, NaClO3 Recommended use For internal transfer between ERCO Worldwide sodium chlorate manufacturing facilities for process purposes Recommended restrictions None known Manufacturer/Importer/Supplier/Distributor information Manufacturer Company name ERCO Worldwide Address 335 Carlingview Drive Unit 1 Etobicoke, M9W 5G8 Canada Telephone Information #: (416) 239-7111 (M- F: 8:00 am – 5:00pm EST) Website http://www.ercoworldwide.com E-mail [email protected] Emergency phone number Canada & USA: 1-800-424-9300 (CHEMTREC) Supplier Refer to Manufacturer 2. Hazard(s) Identification Physical hazards Oxidizing liquids Category 2 Health hazards Acute toxicity, oral Category 4 Environmental hazards Not currently regulated by OSHA, refer to Section 12 for additional information. OSHA defined hazards This mixture does not meet the classification criteria according to OSHA HazCom 2012. Label elements Signal word Danger Hazard statement May intensify fire; oxidizer. Harmful if swallowed. Page 1 of 15 Issue Date: 11/18/2020 Sodium Chlorate Process Liquor De-chromed SN Precautionary statement Prevention Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Keep away from clothing and other combustible materials. Wear protective gloves, protective clothing, eye protection, face protection. Response IF ON SKIN: Wash with plenty of water. Take off contaminated clothing and wash it before reuse. In case of fire: Use water to extinguish. -
Chemical Resistance: Deco-Trowel
CHEMICAL RESISTANCE DECO-TROWEL ® SERIES 223 Tnemec Company, Inc. 6800 Corporate Drive Kansas City, Missouri 64120-1372 +1 816-483-3400 www.tnemec.com © December 16, 2019 by Tnemec Company, Inc. Chem223 Page 1 of 19 CHEMICAL RESISTANCE DECO-TROWEL ® | SERIES 223 COMMON PROBLEM AREAS FOR COATINGS AND SOLUTIONS Problem: Coating Solution: Points of failure Carefully and due to thin spots fully coat in coating Problem: Rough Pinhole Solution: Uneven Undercut Grind smooth welds Problem: Gaps between Solution: plates, coating Continuous can not cover welds Problem: Gaps between Solution: plates, coating Continuous can not cover welds Problem: Coating Sharp surface Solution: contours create Round the thin spots in contours coating Problem: Skip welding Solution: creates gaps Continuous that coating welds can not cover Problem: Skip welding Solution: creates gaps Continuous that coating welds can not cover 2 channels back to back IMPORTANT: Definitions for the terms and acronyms used in this guide to describe the recommended exposures, along with other important information, can be found on the cover page of this guide or by contacting Tnemec Technical Service. Coatings should not be applied in a chemical exposure environment until the user has thoroughly read and understood the product information and full project details have been discussed with Tnemec Technical Service. Tnemec Company, Inc. 6800 Corporate Drive Kansas City, Missouri 64120-1372 +1 816-483-3400 www.tnemec.com © December 16, 2019 by Tnemec Company, Inc. Chem223 Page 2 of 19 CHEMICAL RESISTANCE DECO-TROWEL ® | SERIES 223 ¹ Product is NOT suitable for direct or indirect food contact. Intended Use and temperature information relates to product’s performance capabilities only. -
Systematic Review Protocol for the Inorganic Mercury Salts IRIS Assessment
EPA/635/R-20/239 IRIS Assessment Protocol www.epa.gov/iris Systematic Review Protocol for the Inorganic Mercury Salts IRIS Assessment CASRN 7487-94-7 (Mercuric Chloride) CASRN 1344-48-5 (Mercuric Sulfide) CASRN 10112-91-1 (Mercurous Chloride) February 2021 Integrated Risk Information System Center for Public Health and Environmental Assessment Office of Research and Development U.S. Environmental Protection Agency Washington, DC Systematic Review Protocol for the Inorganic Mercury Salts IRIS Assessment DISCLAIMER This document is a preliminary draft for review purposes only. This information is distributed solely for review purposes under applicable information quality guidelines. It has not been formally disseminated by the Environmental Protection Agency. It does not represent and should not be construed to represent any Agency determination or policy. It is being circulated for comments on its technical clarity and science policy implications. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. This document is a draft for review purposes only and does not constitute Agency policy. ii DRAFT―DO NOT CITE OR QUOTE Systematic Review Protocol for the Inorganic Mercury Salts IRIS Assessment CONTENTS AUTHORS|CONTRIBUTORS|REVIEWERS ........................................................................................................ 1. INTRODUCTION ...................................................................................................................................... 1 1.1.